Changes of tyrosine hydroxylase in parkinsonian brains and in the brains of MPTP-treated mice
- PMID: 1978515
Changes of tyrosine hydroxylase in parkinsonian brains and in the brains of MPTP-treated mice
Similar articles
-
Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys.Adv Neurol. 1993;60:34-9. Adv Neurol. 1993. PMID: 8420148 No abstract available.
-
The dopaminergic nigropallidal projection in primates: distinct cellular origin and relative sparing in MPTP-treated monkeys.Adv Neurol. 1990;53:111-6. Adv Neurol. 1990. PMID: 1978512
-
Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.Neurosci Lett. 2008 Dec 26;448(2):184-8. doi: 10.1016/j.neulet.2008.10.070. Epub 2008 Oct 25. Neurosci Lett. 2008. PMID: 18977411
-
Metabolic aspects of the behavior of MPTP and some analogues.Adv Neurol. 1993;60:186-93. Adv Neurol. 1993. PMID: 8420134 Review. No abstract available.
-
The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.J Neural Transm Suppl. 1986;20:11-39. J Neural Transm Suppl. 1986. PMID: 3091760 Review.
Cited by
-
The catecholamine system in health and disease -Relation to tyrosine 3-monooxygenase and other catecholamine-synthesizing enzymes.Proc Jpn Acad Ser B Phys Biol Sci. 2007 Jan;82(10):388-415. doi: 10.2183/pjab.82.388. Epub 2007 Jan 12. Proc Jpn Acad Ser B Phys Biol Sci. 2007. PMID: 25792770 Free PMC article. Review.
-
Substantia nigra degeneration and tyrosine hydroxylase depletion caused by excess S-adenosylmethionine in the rat brain. Support for an excess methylation hypothesis for parkinsonism.Mol Neurobiol. 1994 Aug-Dec;9(1-3):149-61. doi: 10.1007/BF02816115. Mol Neurobiol. 1994. PMID: 7888091
MeSH terms
Substances
LinkOut - more resources
Medical